The Impact Of Musculoskeletal Disorders On An Australian Population
Funder
National Health and Medical Research Council
Funding Amount
$321,275.00
Summary
A significant proportion of the Australian population experiences pain and disability as a result of musculoskeletal disorders. This research examines a wide range factors related to these conditions and focuses on the knowledge of musculoskeletal disorders and the impact of musculoskeletal conditions on the population. The answers obtained from this research have the potential to positively and significantly impact on the lives of those with musculoskeletal conditions.
The Extent And Impact Of Pharmaceutical Opioids For Chronic Non-cancer Pain
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
There have been dramatic increases in the use of pharmaceutical opioids (PO) for chronic non-cancer pain (CNCP), despite limited data on their long-term effectiveness and an increase in associated harm. This Fellowship provides critical new data to inform both clinicians and policymakers on the global extent of PO for CNCP, trajectories of problematic use and associated morbidity and a unique evaluation of the impact of real-time prescription monitoring program to reduce these harms.
SUcceSS: SUrgery For Spinal Stenosis - A Randomised Placebo-controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$2,303,245.00
Summary
This will be the first placebo-controlled randomised trial of surgery for lumbar spinal stenosis and aims to determine the efficacy and safety of this intervention in decreasing pain and improving disability in this population. The cost-effectiveness of surgery for lumbar spinal stenosis will also be determined.
Epidemiological Approaches To Understanding The Causes And Prevention Of Chronic Disease
Funder
National Health and Medical Research Council
Funding Amount
$546,451.00
Summary
This research program aims to improve understanding of the causes of chronic disease in Australians from childhood to old age. It will also help determine the effectiveness of workplace health and wellbeing programs in preventing disease and the feasibility of reducing mortality in older Australians through vitamin D supplementation.
MULTICENTRE BRONCHIECTASIS STUDY: A Collaborative And International Study Of Bronchiectasis In Indigenous Children.
Funder
National Health and Medical Research Council
Funding Amount
$1,496,414.00
Summary
Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New ....Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New Zealand Maori or Pacific Islander and Alaskan Native) has been initiated. In Indigenous children, we aim to define the natural history of chronic moist cough (those at risk of developing bronchiectasis) and bronchiectasis, identify the risk factors associated with progression from early-mild disease (chronic moist cough) to bronchiectasis and to define the role of continuous antibiotic treatment in the prevention of recurrent pulmonary infections that are very common in these children. We plan to follow up Aboriginal children aged 12 months to 8 years diagnosed with bronchiectasis or chronic moist cough. For those diagnosed with bronchiectasis, after fully informed consent is obtained from the parent(s), the child will be allocated by chance to one of the 2 treatment regimes: (1) Azithromycin once-week or (2) placebo once-week. Children will receive the medication or the placebo for a period of 24 months. All these children will be clinically seen 2x-year by the study's paediatrician and 2x-year by the research nurse for the duration of the study. By documenting, for the first time, the epidemiology and natural history of children with chronic moist cough and bronchiectasis, the study will provide a much-needed rationale for their management. If we can scientifically show that this is true, that Azithromycin is effective in reducing the number of respiratory infections, this would be an achievable advance in the treatment in the field for these children.Read moreRead less
InterLACE: International Collaboration For A Life Course Approach To Reproductive Health And Chronic Disease Events
Funder
National Health and Medical Research Council
Funding Amount
$495,965.00
Summary
Cardiovascular disease and diabetes are major chronic diseases among women. This world-leading research combines data from 7 international and 3 Australian studies of womenÍs health. We will investigate the relationship of reproductive health, from menarche to menopause, with the risk of Type 2 diabetes and cardiovascular disease in later life. Findings will support the development of policies and preventive health strategies to reduce the risk of these chronic diseases.
Building Research Capacity In Epidemiological Studies Of Chronic Disease And Injury
Funder
National Health and Medical Research Council
Funding Amount
$451,716.00
Summary
My vision is to build further capacity in epidemiological research to generate findings that directly inform chronic disease and injury prevention strategies. I will do this by: 1. leading epidemiological research designed to better understand the role and modification of risk factors for chronic disease and injury; 2. developing statistical methodology and tools for the analysis of categorical outcome data that commonly arise in epidemiological studies.
Understanding The Influence Of Agricultural Trade Policy On Food Consumption Patterns, Malnutrition, And Chronic Disease In Thailand And Australia
Funder
National Health and Medical Research Council
Funding Amount
$373,963.00
Summary
Trade policy is often developed without consideration of its effects on health. The Association of South-East Asian Nations (ASEAN) and New Zealand are key trading partners of Australia. Thus the ASEAN-Australia-New Zealand Free Trade Agreement (AANZFTA) was established in 2009. This project aims to analyse the effect of the agricultural trade component of the AANZFTA on food consumption patterns, malnutrition, obesity and chronic disease in Thailand and Australia.